2022-09-29 08:35:05 SGHT Sight Sciences
09/29/22 09/2908:35 09/29/2208:35 | Sight Sciences announces publication of data on TearCare systemSight Sciences announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial, which showed a single treatment with the TearCare System led to superior symptoms relief across the following primary symptoms endpoints compared to a LipiFlow application in patients with more severe forms of DED due to meibomian gland dysfunction, MGD. The OLYMPIA study was a multicenter, masked, randomized controlled trial in which 235 participants received either a single TearCare treatment or a single LipiFlow treatment and were followed for one-month post-treatment. Signs and symptoms were assessed across widely accepted endpoints, including the Ocular Surface Disease Index, Symptom Assessment in Dry Eye, Tear Breakup Time and Eye Dryness questionnaires at baseline and at one month. At one month, both treatments demonstrated a statistically significant improvement in all primary and secondary endpoints. "We are encouraged by the superior clinical findings in this subgroup analysis of advanced dry eye patients from the OLYMPIA trial," said Paul Badawi, CEO of Sight Sciences. "TearCare's intuitive design enables clinicians to thoroughly and comprehensively address the root causes of the signs and symptoms of dry eye due to MGD and these data further confirm our confidence in the clinical and economic value that TearCare brings to patients, providers and payors. On the heels of the publication of this superior symptoms data from OLYMPIA, we also announced the completion of patient enrollment in Sahara, our second major RCT where we are comparing TearCare to the standard of care in dry eye, Restasis. We look forward to the readout of TearCare vs Restasis in the summer of 2023." |
---|
Recommendations
|
Snap outlook worsened again, says Piper Sandler »
21:39 01/31/23 01/3121:39 01/31/2321:39
SNAP
Snap
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
Integer prices upsized offering of $435M convertible notes due 2028 »
21:32 01/31/23 01/3121:32 01/31/2321:32
ITGR
Integer
Integer "announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Atlas Air takes delivery of Boeing's final 747 production aircraft »
21:30 01/31/23 01/3121:30 01/31/2321:30
AAWW
Atlas Air
Boeing
Atlas Air, Inc., a… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
NXP Semiconductors price target raised to $205 from $175 at Oppenheimer »
21:17 01/31/23 01/3121:17 01/31/2321:17
NXPI
NXP Semiconductors
Oppenheimer analyst Rick… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Stryker price target raised to $280 from $250 at Piper Sandler »
21:12 01/31/23 01/3121:12 01/31/2321:12
SYK
Stryker
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Micron exec sells $3.16M in common stock »
20:29 01/31/23 01/3120:29 01/31/2320:29
MU
Micron
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Notable companies reporting before tomorrow's open »
20:25 01/31/23 01/3120:25 01/31/2320:25
TMO
Thermo Fisher
T-Mobile
Altria Group
Boston Scientific
Humana
AmerisourceBergen
Fortive
Dynatrace
Peloton
Brinker
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $5.19... T-Mobile (TMUS), consensus $1.10... Altria (MO), consensus $1.17... Boston Scientific (BSX), consensus 47c... Humana (HUM), consensus $1.46... AmerisourceBergen (ABC), consensus $2.63... Fortive (FTV), consensus 84c... Dynatrace (DT), consensus 21c... Peloton (PTON), consensus (64c)... Brinker (EAT), consensus 52c. ShowHide Related Items >><<
|
Recommendations
|
Oshkosh price target raised to $100 from $93 at Baird »
20:14 01/31/23 01/3120:14 01/31/2320:14
OSK
Oshkosh
Baird analyst Mircea… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 1.1M shares of Invitae today
20:07 01/31/23 01/3120:07 01/31/2320:07
NVTA
Invitae
ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 20.7K shares of Velo3D today
20:07 01/31/23 01/3120:07 01/31/2320:07
VLD
Velo3D
ShowHide Related Items >><<
|
Earnings
|
Waste Management sees FY23 revenue growth of 4.0% to 5.5% »
19:17 01/31/23 01/3119:17 01/31/2319:17
WM
Waste Management
The projected growth rate… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Waste Management reports Q4 EPS $1.30 , consensus $1.41 »
19:13 01/31/23 01/3119:13 01/31/2319:13
WM
Waste Management
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Vorwerk Group SE downgraded to Hold from Buy at Jefferies »
19:11 01/31/23 01/3119:11 01/31/2319:11
FRVWY
Vorwerk Group SE
Jefferies analyst Martin… Story temporarily locked. |
Recommendations
|
Sysco well positioned to drive accelerating growth, says Stephens »
19:02 01/31/23 01/3119:02 01/31/2319:02
SYY
Sysco
Stephens analyst Joshua… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Marin Software announces new integration with Yahoo »
18:58 01/31/23 01/3118:58 01/31/2318:58
MRIN
Marin Software
Marin Software announced… Story temporarily locked. |
Hot Stocks
|
Pfizer CEO: Our best days are still ahead of us »
18:49 01/31/23 01/3118:49 01/31/2318:49
PFE
Pfizer
In an interview on… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Dover price target raised to $165 from $144 at Baird »
18:42 01/31/23 01/3118:42 01/31/2318:42
DOV
Dover
Baird analyst Mircea… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Linamar upgraded to Outperform from Market Perform at BMO Capital »
18:37 01/31/23 01/3118:37 01/31/2318:37
LIMAF
Linamar
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Magna upgraded to Outperform from Market Perform at BMO Capital »
18:37 01/31/23 01/3118:37 01/31/2318:37
MGA
Magna
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Martinrea upgraded to Outperform from Market Perform at BMO Capital »
18:36 01/31/23 01/3118:36 01/31/2318:36
MRETF
Martinrea
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Canadian Tire upgraded to Outperform from Market Perform at BMO Capital »
18:35 01/31/23 01/3118:35 01/31/2318:35
CDNAF
Canadian Tire
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Metro downgraded to Market Perform from Outperform at BMO Capital »
18:34 01/31/23 01/3118:34 01/31/2318:34
MTRAF
Metro
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
18:32 01/31/23 01/3118:32 01/31/2318:32
CACC
Credit Acceptance
O-I Glass
Stryker
Edwards Lifesciences
AMD
Mondelez
Jasper Therapeutics
Snap
Hawaiian Holdings
Electronic Arts
Match Group
Western Digital
Varex Imaging
Juniper
Super Micro Computer
Ashland
Houlihan Lokey
Taysha Gene Therapies
Poseida Therapeutics
Check out this evening's… ShowHide Related Items >><<
|
Hot Stocks
|
Mesoblast resubmits BLA to FDA for remestemcel-L »
18:31 01/31/23 01/3118:31 01/31/2318:31
MESO
Mesoblast
Mesoblast Limited… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Boston Properties cuts FY23 FFO view to $7.08-$7.18 from $7.15-$7.30
18:28 01/31/23 01/3118:28 01/31/2318:28
BXP
Boston Properties
Consensus $7.18. ShowHide Related Items >><<
|